NHS Plymouth Introduces Tunstall's Telehealth Solutions

TunstallNHS Plymouth has partnered with Tunstall to implement a telehealth programme that will support the management of long-term conditions (LTCs) for patients in Plymouth.

The telehealth initiative will give patients greater control over their condition, allowing them to monitor it from home with the reassurance that professional support is available if required. This will significantly reduce the hospital admission rate for patients living with LTCs, giving them greater freedom and the opportunity to live more independent lives.

NHS Plymouth's decision to undertake a telehealth programme came about following the need to drive efficiency within its services by tackling the rising costs of treating long-term conditions whilst at the same time improving patients' quality of life. The programme will initially be available to 100 patients living chronic obstructive pulmonary disease (COPD), and/or chronic heart failure (CHF).

Jane Griffin, Lead Commissioning Manager of Long Term Conditions for NHS Plymouth, said: "We were aware of the possible benefits of telehealth from a number of schemes carried out by other PCTs, and so the decision was made to implement a small-scale programme to see if it could be as beneficial for us and our patients' needs. This is an opportunity for NHS Plymouth to use technological advances for the benefit of our patients. Our aim is to support patients to self care and give them greater independence and we are confident that the telehealth programme will enable this to happen."

Simon Arnold, Tunstall's Managing Director said: "Plymouth's new telehealth programme will deliver efficiency gains by helping the NHS to manage long-term conditions more cost-effectively, reducing unplanned admissions to emergency and secondary care and supporting patients in the home environment. Patients will be able to actively manage their own conditions, whilst being able to live more independently without the constraints of frequent and often lengthy hospital admissions."

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...